Innovation @ Chikujee
THE Aayush personalized Health care PLATFORM
Increased scientific and
technological complexity of drug
discovery along with its increased
price tag is driving the
biopharmaceutical companies to find
integrated and more efficient means
of drug development and
commercialization. Greater access to
healthcare in developed as well as
emerging markets and advances in
science create opportunities to
enhance the lives of patients at
affordable prices, through
successful execution of innovation.
This trend is evident in the recent
initiatives to develop combination
products. However, we feel such
initiatives will have temporary
impact on the efficient and patient
friendly personalized medicine. We
at Chikujee, are developing
innovative platform based product
engines that integrates diagnostics,
targeted therapeutics and clinical
monitoring of cancer treatment in a
single personalized product.
Healthcare innovation generally
refers to the drug discovery and
development process – the
translation of fundamental science
into new drugs, vaccines, devices
and diagnostic tests. This type of
innovation requires significant
investment and teams commanding
specialized, yet complementary,
skills. Such an environment provides
an excellent proving grounds for
innovation oriented companies to
achieve rapid and sustainable
growth. A major shortcoming of the
current system in drug development
life cycle is lack of continuity in
terms of common monitoring criteria
for molecular diagnostics, targeted
drug delivery and at-site drug
efficacy. Each component of drug
development life cycle operates as
an independent silo, without common
quality attributes that are
continued throughout the development
process. This disconnects typically
results in significant rates of drug
development failures at different
phases of development, increased
costs as well as lack of consistency
in quality of the drugs.
Companies that will successfully
implement these critical unmet needs
with innovative strategies are
expected to be the leaders of the
future in biopharmaceuticals domain.
We
have developed Aayush technology
platform that is based on
multifunctional
nanoparticles-NanoBindi- that
promises to open the doors to the
development of integrated
personalized healthcare product
portfolios.